The stability of an in-vitro diagnostic (IVD) medical device reagent is the ability to maintain the performance characteristics over a de ined time interval. The stability studies are performed to demonstrate that the product remains viable under the speci ied storage condition until the claimed time period. Since, stability of the IVD cannot be directly assessed through accuracy, performance attributes or customer testing; it is the responsibility of the manufacturer to evaluate the performance of the product by identifying critical factors affecting the stability through developing stability plan, stability protocol and conducting real-time stability studies, accelerated stability studies, in-use stability studies and transport simulated stability studies.
INTRODUCTION
The stability of an in-vitro diagnostic (IVD) medical device reagent re lects the maintenance of performance characteristics over a de ined time interval (ISO , 2011). The purpose of these stability studies involves the establishment and veri ication of the time interval and the storage conditions to demonstrate stable performance characteristics of an IVD (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017). The article provides manufacturers, the possible approaches to determine stability. In further, helps to establish stability attributes for laboratory-developed test methods. The stability of the product is affected by various internal and external factors. Just like through bias, accuracy, precision or other performance attributes, customer testing cannot directly assess the stability of product (Evaluation of stability of In-vitro Diagnostic Reagents, 2009). Thus, it is a regulatory requirement for the manufacturer to prove the stability of an IVD (Establishing component stability of an in-vitro diagnostic medical device, 2019).
Stability de ined as the ability of an IVD reagent to maintain its performance characteristics within the limits speci ied by the manufacturer. Stability applies to all In-Vitro Diagnostic reagents, calibrators, sample diluents, and controls. The claimed stability is usually based on the data obtained from real-time testing. In order to provide preliminary stability claims or to qualify changes relative to the products with already established real-time stability claim, accelerated stability studies are performed. Subsequently, such claims should be inalized by performing real-time stability studies (Schedule, 2016) . A stability evaluation plan for a particular product should involve logistics of performing stability studies, recommend data analyses, document stability claims, assess product transport con-dition on stability claims, stability veri ication and perform real-time, accelerated, and in-use stability studies (Establishing component stability of an invitro diagnostic medical device, 2019). A stability claim should be developed by demonstrating that the product meets the requirements at the start and end of the speci ied period (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017).
MATERIALS AND METHODS

Need and requirement for stability testing of IVD
Stability testing is performed to provide evidence on how the quality and performance of an IVD varies with time under the in luence of various environmental factors such as temperature, humidity and light, and to establish shelf life for the IVD and recommended storage conditions.
Minimum number of batches
The important sources of the variation should be identi ied through risk assessments. The stability testing should be carried out on more than one batch, due to the impact of batch-to-batch variability.
1. Minimum of three batches to verify shelf life (real-time).
2. Minimum of one batch to ensure the in-use claims.
3. Minimum of three batches for extension of shelf-life.
4. Minimum of one batch for extension of in-use claims.
5. Minimum of one batch for simulated transport testing.
Assessment of liquid components
For the components, those are diluted or reconstituted from a freeze-dried state before use, needs special in-use stability studies. It is required to ensure that these products need occasional moving, such that the components are in direct contact between the liquid contents and different parts of the container (such as the container closure system).
Specimens for the stability testing panel
The stability testing panel includes wellcharacterized specimens or other components that are used for monitoring, design control, inprocess control, and design validation. These specimens must re lect performance claims of the IVD. The specimens are selected, based on where the product is intended to be used in WHO member states.
In case of multiple specimen types, the stability plan should ensure to meet its claims for an individual specimen to re lect the overall performance and shelf-life of the product. The results and decisions must be documented and traceable.
The stability testing panel needs to be validated and establish rejection & replacement criteria.
The validation of stability testing panel members used is very crucial, and storage of validated protocol is not always possible to do.
Each panel member has been chosen to provide attributes relevant to the intended use, where each member assign an expected value, that is used to set acceptance criteria for that panel member. These expected values are relevant to the outputs of the particular methodology. Panel member meets the acceptance criteria; re lect the stability of the inal product.
Time points
The study design needs a maximum of 3 testing intervals;
1. An initial baseline test.
2.
A test at the point beyond the claimed stability limit.
One point in between.
This design represents a high risk and waste of time and resources. When the design fails to meet the acceptance criteria but provides some information regarding deterioration/lack of deterioration of the IVD component, thus, it needs still an effective approach, which can be achieved by incorporating additional predetermined intermediate time point intervals.
Manufacturer in prior should determine the no. of test points, length of the testing interval and choose panel members to be tested at these intermediate test points and mention in the stability plan/protocol. In addition, it requires to analyze zero time values and variance.
Duration of testing
Stability testing should be performed beyond the shelf-life determined by the user needs. Minimum of one test point beyond the predetermined user requirement should be conducted.
Length of the time period
It is based on the risk assessment plan and provides protection, in case of an unexpected failure of the IVD, because the extrapolation from the earlier time point is not acceptable.
"Zero time" values and variability
The value of each measured characteristic should be measured independently for each lot during the stability study. Analysis of the data obtained after the study helps to determine if any statistically signi icant change has occurred to the measured parameters during the study in any batches. These changes are evaluated to decide if they could represent some important changes that are not detected during the stability testing.
Zero time values
These values are established by evaluating each characteristic for each batch on ive or more occasion, where each occasion may involve a different day, a different set of equipment's or different operator to examine potential sources of analytical variation. This value in further evaluates the variance of measured characteristic with freshly made materials.
RESULTS AND DISCUSSION
Shelf-life stability studies
Shelf life is the period of time for which objective evidence exists to demonstrate that a product remains viable under recommended storage conditions prior to the last day of use/expiry date (Evaluation of stability of In-vitro Diagnostic Reagents, 2009), i.e. shelf life is a period of time from the date of manufacture to the expiry date (Bs/En Iso 23640, 2015). Product stability claims are typically based on data from real-time testing. Testing product under more stressful environmental conditions (accelerated testing) may be useful to establish preliminary stability claims or to qualify changes in the product's formulation or container closure system relative to products with established real-time stability claims. Accelerated stability data is not suficient to support the claimed shelf-life; hence, the data should be veri ied and inalized through realtime testing ( 
Shelf life studies
Real-time stability studies
Real-time stability studies are designed to establish or verify the shelf life of the IVD reagent when exposed to the conditions speci ied by the manufacturer. Factors that can affect the stability of an IVD reagent include temperature, humidity, light, transport conditions, vibration, etc. Testing should be performed on at least three different lots manufactured under conditions equivalent to routine production conditions (STED, 2011).
For real-time testing, the test components are stored for temperature as per user requirement (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017). The study is extended over a period longer than target shelf-life until signi icant degradation in the performance of IVD can be seen (In-vitro diagnostic reagent, 2000).
The test material is stored in the inal container at a recommended storage temperature throughout the complete stability study.
The results are predicted through Levy-Jennings plot.
A sequential approach is used in case of real-time stability study, where IVDs before placing into inuse study or shelf-life under recommended storage condition, subjected to stress-simulating transport (Jeffrey et al., 2016) .
When IVDs are stored for a long period after manufacture and before shipping, they are irst stored in recommended storage condition, then under stressed transport condition and inally back into recommended storage condition during the course of study (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017). Figure 2 describes the real-time stability study process.
Accelerated stability studies
Accelerated stability studies are designed to increase the rate of chemical and/or physical degradation, or change, of an IVD reagent by using environmental stress conditions to predict shelf life (New Medical Device Rules , 2017) 10 . The design of an accelerated stability evaluation includes stress conditions of temperature, humidity, light or vibration.
For accelerated stability testing, the test material is stored at different elevated temperature, depending on the recommended initial storage temperature for a prede ined period of time through increased rate of through increased rates of physical/chemical degradation caused by those extreme environmental conditions (Establishing component stability of an in-vitro diagnostic medical device, 2019).
In further, the study is conducted until a signi icant deterioration of the product is seen. The results are obtained in a relatively short period of time (In-vitro diagnostic reagent, 2000).
Arrhenius equation is used to predict the shelf-life of the product. These results do not re lect observed performance under recommended actual storage condition but provide information about degradation of reagent & IVD components (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017). 
Component stability studies
These studies involve antimicrobial and desiccant studies for those components that are made as per inalized approved manufacturing speci ications on quali ied equipment to meet inalized approved inprocess quality control speci ications (Establishing stability of an in-vitro diagnostic for WHO Prequaliication, 2017).
Component stability studies provide evidence to ensure the component shelf-life does not restrict the inal IVD product shelf-life. During these studies, the components are prepared in bulk and used in several different lots of a completed IVD.
For minimum shelf-life studies, three batches of components are veri ied. And based on risk assessment factors related to variability, one or more subsequent batches can be incorporated.
In the case of component stability, there are two shelf-lives to be evaluated for 1. Bulk material stored before transferring to the inal packaging.
Components in its inal packaging (Establishing component stability of an in-vitro diagnostic medical device, 2019).
Component stability can be evaluated from the functionality of the batch and also by factors that might transform over time, such as turbidity, pH, microbial contamination, change in colour, etc. By these studies, one can distinguish between the turbidity occurred from heat/cold denaturation and turbidity occurred from microbial contamination.
It is necessary to ensure whether the shelf-life of the components made from freshly made constituents and components made from stored raw materials will remain same (ISO , 2011).
To ensure that the IVD has functioned as expected and performed as expected during the use, assayspeci ic control materials provided by the manufactures are used (ISO:15198, 2004).
Effectiveness of the antimicrobial preservative used in the IVD must be demonstrated throughout its shelf-life to prevent contamination of the product during storage and use (Jeffrey et al., 2016) .
Studies to be performed to ensure the desiccant used in the IVD does not affect its stability over the whole claimed shelf-life during transport, storage and in-use condition (Establishing component stability of an in-vitro diagnostic medical device, 2019).
Stability during transport
Transport stability studies ensure that the claimed shelf-life is not affected during & after the transport (STED, 2011). These studies are performed by the manufacturer to evaluate the tolerance of the IVD through stress simulated product exposure to different physical conditions such as inversion, physical handling, vibration, stacking and environmental conditions like temperature, humidity, etc. during and after transportation from the manufacturer to inal user (Evaluation of stability of In-vitro Diagnostic Reagents, 2009).
In-Use Stability Studies
Duration of time over which the performance of an IVD reagent within its expiration date remains within speci ied limits, after opening the container system supplied by the manufacturer and put into use under proper standard operating conditions (e.g. storage on the instrument) (New Medical Device Rules , 2017).
Open or "In-use" stability studies can be used to evaluate multi-use reagents; this allows a speci ic recommendation to test the performance after their opening, reconstitution/dilution or exposure to user environmental conditions. These studies are designed to simulate the product in use. They re lect the routine conditions of use (Evaluation of stability of In-vitro Diagnostic Reagents, 2009) e.g. on-board stability, reconstitution, and open-vial/bottle stability (In-vitro diagnostic reagent, 2000).
In order to obtain the best results and con irm the claimed in-use life throughout its shelf-life, the testing should be done both at the starting and end of their shelf-lives and after the simulated transport challenge
On-board/Open-vial stability studies (In-vitro diagnostic reagent, 2000)
These studies determine the stability of IVD after irst opening of the primary container either in a refrigerator at 2-8 o C or in on-board clinical chemistry analyzer in a refrigerated compartment. In both the cases, the testing is done as per a predeined protocol for a period up to 28days by storing the IVD reagent in the inal reagent vial. The conclusions are derived from prede ined acceptance criteria.
Reconstituted stability testing (In-vitro diagnostic reagent, 2000)
These studies are usually applicable for lyophilized product.
The test materials are tested at prede ined time intervals after reconstitution. The results are compared to the results obtained from the freshly reconstituted test materials.
The following Table 1 illustrates some of the differences between real-time and accelerated stability studies.
Stability study design (Evaluation of stability of Invitro Diagnostic Reagents, 2009)
The study designs are used to enter and withdraw the testing products from the test storage conditions of the stability study.
Classic Design
Isochronous Design
Each protocol design has different strengths, associated risks and prerequisites.
Classic Design
The classic study design involves placing the test product at testing storage conditions at the beginning of the study and the product is withdrawn for further testing at de ined time points throughout the study period. The study does not any prerequisites to be used.
Merit
The results are obtained on the given test day itself.
Demerit
1. The design involves long-term variability of the study process, sample variability, instrument variability, laboratory environmental luctuations, etc., over the study period.
2. In case of any instrument failure during the study, shifting test results from one instrument to another has a great dif iculty during classic design.
Isochronous Design
The isochronous study design is similar to classic design, involving the placing of test product at testing storage conditions at the beginning of the study and withdrawn for further testing and placed into presumed stable storage condition till the end of the study for a prede ined time points during the study. The study is either implemented in a staggered start/end condition. 
Stability report
Once the study is completed, the results should be summarized instability report.
The report should re lect the details regarding the product tested, the objective of the study, test conditions, results and conclusions (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017). The report should be properly documented and should be easily traceable along with study plan, protocols and input requirements (Bs/En Iso 23640, 2015).
Criteria's for stability studies to be fulilled (Establishing stability of an in-vitro diagnostic for WHO Prequali ication, 2017)
1. Prior to initiation, studies must be fully documented with risk evaluations, plans and protocols.
2. Studies and risk management must be taken into consideration, the conditions that are likely to be encountered in which the device is intended to be used.
3. Devices must be subjected to stress transport simulation before being used to establish any form of stability data.
4. Transport simulation studies must cover the extreme environmental conditions ascertained during risk evaluations 5. Devices used in any stability studies must be similar to inalized manufacturing speci ications, including packaging, labelling, etc.
6. Suf icient numbers of independent lots of the device must be evaluated to check, inter-lot variability 7. If critical components of the device are assigned lives irrespective of the life of the device, the various forms of stability of the device must be proven with those reagents at different stages of their assigned lives 8. If any inter-independent lot variability is found, the manufacturer must provide evidence that subsequent lots will not have worse stability than that claimed 9. If the analytic function of the device is out of speci ication from any cause, including stability failure, the control material must claim to prove the functionality of the device, in addition to any other studies.
CONCLUSIONS
IVD's after stability studies should provide information on safety, quality and performance. Their performances are expected to be accurate and reliable till the claimed shelf-life. The article emphasizes on providing IVD manufacturers, the probable ways and design methods to determine stability shelflife. Additional information includes assessment of product stability claims during transport, component stability testing, creating a stability testing plan, stability protocol and stability report. These guidelines can be used by IVD manufacturers and regulators. In addition, clinical laboratory personnel can use this information to establish stability attributes for laboratory-developed test methods. There is a need to prepare country-speci ic guidelines for testing stability for IVD.
